Dan Liu
Corporate Officer/Principal bij Beijing Advaccine Biotechnology Co., Ltd.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Qing Ling Yu | F | 58 |
Beijing Advaccine Biotechnology Co., Ltd.
 Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 15 jaar |
| Bin Wang | M | 66 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 15 jaar |
| Jian Qun Peng | F | 39 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 jaar |
| Xiao Yan Liu | M | 40 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 jaar |
| Wen Wei Tu | M | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 jaar |
| Lu Nan Zhang | F | 36 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 7 jaar |
| Guo Hao Jin | M | 35 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 jaar |
| Guan Chun Dai | M | 47 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 jaar |
| Zhi Yuan Nian | M | 68 |
Jilin University
| 21 jaar |
| Wai Ching Au | F | - |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | - |
| Zhi Yun Yu | M | 45 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 jaar |
| Ji Ma | M | 62 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | - |
| Zhou Lu | F | 52 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 12 jaar |
| Gan Zhao | M | 44 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 9 jaar |
| Ai Hua Dong | F | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 9 jaar |
| Hong Qin | F | 57 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 3 jaar |
| Xue Qin Wu | F | 51 |
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | 4 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Zheng Xin Jiang | M | 66 |
Jilin University
| 6 jaar |
| Qiang Li | M | 53 |
Jilin University
| 12 jaar |
| Yuan Chen Liu | M | 43 |
Jilin University
| 6 jaar |
| Zhi Su | M | 47 |
Jilin University
| 8 jaar |
| Guang Hua Wang | M | 39 |
Jilin University
| 6 jaar |
| Hong Jun An | M | 48 |
Jilin University
| 5 jaar |
| Weijia Li | F | 47 |
Jilin University
| - |
| Dan Dan Shao | F | 46 |
Jilin University
| 3 jaar |
| Yan Xu | F | 41 |
Jilin University
| 2 jaar |
| Xu Tang | F | 42 |
Jilin University
| 3 jaar |
| Xin Lu | M | 50 |
Jilin University
| 2 jaar |
| Jun Gui Bai | M | 61 |
Jilin University
| 2 jaar |
| Ti Jun Yang | M | 58 |
Jilin University
| 3 jaar |
| Shuang Quan Kong | M | 50 |
Jilin University
| 1 jaar |
| Huang Tianbo | M | 38 |
Jilin University
| 4 jaar |
| Ming Hui Liu | M | 57 |
Jilin University
| 3 jaar |
| Lirong Han | M | 61 |
Jilin University
| 3 jaar |
| Xiao Tong Jin | M | 60 |
Jilin University
| 3 jaar |
| Xue Jun Li | M | 61 |
Jilin University
| 3 jaar |
| Jiafu Sun | M | 52 |
Jilin University
| 4 jaar |
| Dong Sheng Gao | M | 55 |
Jilin University
| 2 jaar |
| Jian Fang Liu | M | 49 |
Jilin University
| 3 jaar |
| Jin Song Zhang | M | 59 |
Jilin University
| 4 jaar |
| Xiao Luo | M | 40 |
Jilin University
| 4 jaar |
| Chun Na Zhang | F | 46 |
Shenyang Pharmaceutical University
| 4 jaar |
| Hua Tao | M | 60 |
Jilin University
| 2 jaar |
| Da Bing Li | M | 49 |
Jilin University
| 3 jaar |
| Tie Qiang Liu | M | 45 |
Jilin University
| 4 jaar |
| Gui Hua Li | F | 46 |
Shenyang Pharmaceutical University
| 4 jaar |
| Yong Heng Dong | M | 45 |
Jilin University
| 3 jaar |
| Jing Xin Xu | F | 46 |
Shenyang Pharmaceutical University
| 4 jaar |
| Yan Wang | M | 46 |
Jilin University
| 4 jaar |
| Yu Liu | M | 40 |
Jilin University
| 4 jaar |
| Cheng Qian | M | 38 |
Jilin University
| 4 jaar |
| Le Le Zhang | F | 46 |
Shenyang Pharmaceutical University
| 4 jaar |
| Yi Xing | M | 44 |
Jilin University
| 4 jaar |
| Ping Liu | F | 44 |
Shenyang Pharmaceutical University
| 4 jaar |
| San Ming Li | M | 67 |
Shenyang Pharmaceutical University
| 3 jaar |
| Wei Wei Xia | F | 44 |
Jilin University
| 4 jaar |
| Hui Ni Huang | F | 41 |
Jilin University
| 4 jaar |
| Zong Xin Zhang | M | 52 |
Jilin University
| 3 jaar |
| Li Na Wang | F | 46 |
Jilin University
| 4 jaar |
| Tai Ming Zu | M | 49 |
Jilin University
| 2 jaar |
| Zhuo Li | M | 51 |
Jilin University
| 4 jaar |
| Ru Li | F | 45 |
Shenyang Pharmaceutical University
| 4 jaar |
| Shi Lei Li | M | 38 |
Jilin University
| 4 jaar |
| Xue Qing Ding | M | 60 |
Jilin University
| 4 jaar |
| Rui Zhang | M | 40 |
Jilin University
| 4 jaar |
| Shu Guang Fan | M | 60 |
Jilin University
| 2 jaar |
| Qi Yu Zheng | M | 69 |
Jilin University
| 1 jaar |
| Wei Chen | M | 45 |
Jilin University
| 4 jaar |
| Shouwang Yang | M | 41 |
Jilin University
| 4 jaar |
| Xin Li | M | 52 |
Jilin University
| 3 jaar |
| Wei Dong Xu | M | 65 |
Jilin University
| 3 jaar |
| Xiu Feng Yu | M | 60 |
Jilin University
| 4 jaar |
| Ri Gao Sun | M | 52 |
Shenyang Pharmaceutical University
| 4 jaar |
| David Y. Lu | M | 42 |
Jilin University
| 4 jaar |
| Hai Gao | M | - |
Jilin University
| 4 jaar |
| Ju Bo Liu | M | 51 |
Shenyang Pharmaceutical University
| 5 jaar |
| Xiao Ming Ling | M | 51 |
Jilin University
| 3 jaar |
| Jin Liu | M | 41 |
Jilin University
| 4 jaar |
| Peng Cheng | M | 50 |
Jilin University
| 2 jaar |
| Chun Mei Zhang | F | 40 |
Jilin University
| 4 jaar |
| Ping Zhou | M | 49 |
Jilin University
| 2 jaar |
| Zhao Peng Hu | M | 51 |
Shenyang Pharmaceutical University
| 4 jaar |
| Qun Yu | M | 56 |
Jilin University
| 3 jaar |
| Yan Min Tang | F | 51 |
Shenyang Pharmaceutical University
| 4 jaar |
| Jing Quan Liu | M | 54 |
Jilin University
| 4 jaar |
| Zhi Jun Li | M | 43 |
Jilin University
| 4 jaar |
| Shi Wang | M | 42 |
Jilin University
| 4 jaar |
| Xu Jie Ying | M | 51 |
Shenyang Pharmaceutical University
| 4 jaar |
| Song Yu Han | M | 41 |
Jilin University
| 4 jaar |
| Hongxuan Zhou | M | 44 |
Jilin University
| 1 jaar |
| Juan Xu | F | 43 |
Jilin University
| 4 jaar |
| Hong Jiang | M | - |
Jilin University
| 4 jaar |
| Sha Liu | F | - |
Jilin University
| 4 jaar |
| Yu Guo Zhang | M | 53 |
Jilin University
| 4 jaar |
| Bo Su | M | 39 |
Jilin University
| 4 jaar |
| Ming Kuan Jiang | M | 42 |
Jilin University
| 4 jaar |
| Kevin Wu | M | - |
Jilin University
| 5 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| China | 97 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
